Related Experiment Video
Updated: May 28, 2026

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
Acceptance of long-acting reversible contraceptive methods by adolescent participants in the Contraceptive CHOICE
Renee Mestad1, Gina Secura, Jenifer E Allsworth
1Department of Obstetrics and Gynecology, Washington University, St. Louis School of Medicine,St. Louis, MI 63110-1501, USA. mestadr@upstate.edu
Background:
Adolescent women have a high risk of unintended pregnancy. Currently, there are little data about their choice to initiate long-acting reversible contraception (LARC).
Study Design:
We evaluated the association of age and preference for a LARC vs. a non-LARC method among adolescent participants in the Contraceptive CHOICE Project, comparing those aged 14-17 years to adolescents aged 18-20 years. We then analyzed the association between age and choice of the implant vs. the intrauterine device (IUD) among adolescents.
Results:
Of the 5086 women enrolled, 70% (n=3557) of participants chose a LARC method. Among adolescents aged 14-20 years, 69% of 14-17-year-olds chose LARC, while 61% of 18-20-year-olds chose LARC (relative risk 1.16, 95% confidence interval 1.03-1.30). Among adolescents choosing a LARC method, 63% (n=93/148) of the 14-17-year-olds chose the implant, whereas 71% (n=364/510) of the 18-20-year-olds chose the IUD.
Conclusion:
Long-acting reversible contraception use is clearly acceptable and common among adolescents enrolled in the Contraceptive CHOICE Project, with the younger group being most interested in the implant.
More Related Videos
Related Concept Videos
Birth Control Methods
Intrauterine Drug Delivery Systems
Longitudinal Research
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Persuasion Strategies
Oral Drug Delivery Systems: Continuous-Release Systems

